Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390
- PMID: 37185678
- DOI: 10.2337/dc22-2300
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390
Comment in
-
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.Diabetes Care. 2023 May 1;46(5):e121-e122. doi: 10.2337/dci23-0016. Diabetes Care. 2023. PMID: 37185689 No abstract available.
Comment on
-
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer.Diabetes Care. 2023 Feb 1;46(2):384-390. doi: 10.2337/dc22-1148. Diabetes Care. 2023. PMID: 36356111
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical